These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11446463)

  • 1. Effects of a non-steroidal (ketorolac tromethamine) and a steroidal (dexamethasone) anti-inflammatory drug on refractive state and ocular growth.
    Luu CD; Foo H; Crewther SG; Crewther DP
    Clin Exp Ophthalmol; 2001 Jun; 29(3):175-8. PubMed ID: 11446463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis.
    Schechter BA
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):507-11. PubMed ID: 18433352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the use of ophthalmic ketorolac tromethamine 0.4%.
    Perry HD; Donnenfeld ED
    Expert Opin Pharmacother; 2006 Jan; 7(1):99-107. PubMed ID: 16370927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of continuous light on experimental refractive errors in chicks.
    Guo SS; Sivak JG; Callender MG; Herbert KL
    Ophthalmic Physiol Opt; 1996 Nov; 16(6):486-90. PubMed ID: 8944195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C; Neubauer AS; Kampik A; Schönfeld CL
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits.
    Fraser-Smith EB; Matthews TR
    J Ocul Pharmacol; 1988; 4(2):101-9. PubMed ID: 3262701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery.
    Price MO; Price FW
    Curr Med Res Opin; 2004 Dec; 20(12):2015-9. PubMed ID: 15701218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP; De Castro LE; Vroman DT; Solomon KD
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
    Bucci FA; Waterbury LD
    Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
    Solomon KD; Cheetham JK; DeGryse R; Brint SF; Rosenthal A
    Ophthalmology; 2001 Feb; 108(2):331-7. PubMed ID: 11158809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study.
    Solomon KD; Vroman DT; Barker D; Gehlken J
    J Cataract Refract Surg; 2001 Aug; 27(8):1232-7. PubMed ID: 11524195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.
    Gordon YJ; Araullo-Cruz T; Romanowski EG
    Arch Ophthalmol; 1998 Jul; 116(7):900-5. PubMed ID: 9682703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of early steroid treatment after PRK on clinical and refractive outcomes.
    Vetrugno M; Maino A; Quaranta GM; Cardia L
    Acta Ophthalmol Scand; 2001 Feb; 79(1):23-7. PubMed ID: 11167281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.
    Sher NA; Golben MR; Bond W; Trattler WB; Tauber S; Voirin TG
    J Refract Surg; 2009 Feb; 25(2):214-20. PubMed ID: 19241773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both the central and peripheral retina contribute to myopia development in chicks.
    Wang JC; Chun RK; Zhou YY; Zuo B; Li KK; Liu Q; To CH
    Ophthalmic Physiol Opt; 2015 Nov; 35(6):652-62. PubMed ID: 26271934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical diclofenac and ketorolac on patient discomfort and corneal sensitivity.
    Narváez J; Kroll P; Guzek JP
    J Refract Surg; 2002; 18(2):145-8. PubMed ID: 11934203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
    Waterbury LD; Silliman D; Jolas T
    Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constant light rearing disrupts compensation to imposed- but not induced-hyperopia and facilitates compensation to imposed myopia in chicks.
    Padmanabhan V; Shih J; Wildsoet CF
    Vision Res; 2007 Jun; 47(14):1855-68. PubMed ID: 17512028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.